Clinical and laboratory research progress of atropine in the prevention and control of myopia

Journal Title: Eye Science (Yanke Xuebao) - Year 2022, Vol 37, Issue 5

Abstract

As the population of myopia grows rapidly, myopia has become a hot issue of global concern. Preventing myopia and slowing the progression of myopia to reduce the occurrence of pathological myopia and reduce the cost of myopia is the main purpose of related clinical work and scientific researches. Currently, atropine is the main drug for the prevention and control of myopia, and both laboratory studies and clinical trials have confirmed its effect. The American Academy of Ophthalmology recommends the use of 0.01% atropine, which is reported to be 50% to 53% effective in preventing and controlling myopia. This review collects the clinical and laboratory researches in decades to summarize the study progress in atropine for preventing and controlling myopia, including the clinical application effects, the influencing factors such as concentration, individual differences, bioavailability, and the related mechanisms. We also highlight the existing difficulties and challenges in the use of atropine in clinic.

Authors and Affiliations

Chunwen TAO, Liang LIN, Yuwen WANG, Jingjing XU, Yangjun CHEN, Kaihui NAN

Keywords

Related Articles

Application of information management system based on Wechat platform in clinical genetic testing for ophthalmic genetic diseases

[Objective:] To optimize the follow-up approach for patients with ophthalmic genetic diseases through informational technology, reduce the loss rate of cases, and faciliate the efficient operation of the clinical laborat...

Application of optical coherence tomography angiography in ocular anterior segment diseases

Optical coherence tomography angiography (OCTA) is a noncontact, noninvasive, and rapid angiography technique. It provides vascular images by detecting changes in the optical coherence tomography (OCT) signal of red bloo...

Efficacy and safety assessment of ultrapulse carbon dioxide laser in treating eyelid tumors

[Objective:] To evaluate the efficacy and safety of ultrapulse carbon dioxide (CO₂) laser in the treatment for various types of eyelid tumors. [Methods:] A total of 50 patients, including 12 males and 38 females, with ey...

Bibliometric and visualized analysis of global dry eye research from 2016 to 2020

[Objective:] To understand the literature distribution characteristics of dry eye research in the world in the last 5 years, and to analyze the research trend and hotspots in this field. [Methods:] Based on the Web of Sc...

Misdiagnosis of thyroid-associated ophthalmopathy combined with ocular myasthenia gravis: a case report

A 47-year-old man presented with binocular diplopia and hypertropia of left eye for 2 months. He was diagnosed with Graves’ disease for half a year. The patient was protruding in both eyes with hypertropia and limited of...

Download PDF file
  • EP ID EP763673
  • DOI 10.3978/j.issn.1000-4432.2022.04.07
  • Views 17
  • Downloads 0

How To Cite

Chunwen TAO, Liang LIN, Yuwen WANG, Jingjing XU, Yangjun CHEN, Kaihui NAN (2022). Clinical and laboratory research progress of atropine in the prevention and control of myopia. Eye Science (Yanke Xuebao), 37(5), -. https://www.europub.co.uk/articles/-A-763673